Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Current Deferred Revenue (2018 - 2025)

AdaptHealth has reported Current Deferred Revenue over the past 8 years, most recently at $59.8 million for Q4 2025.

  • Quarterly results put Current Deferred Revenue at $59.8 million for Q4 2025, up 71.25% from a year ago — trailing twelve months through Dec 2025 was $59.8 million (up 71.25% YoY), and the annual figure for FY2025 was $59.8 million, up 71.25%.
  • Current Deferred Revenue for Q4 2025 was $59.8 million at AdaptHealth, roughly flat from $59.9 million in the prior quarter.
  • Over the last five years, Current Deferred Revenue for AHCO hit a ceiling of $59.9 million in Q3 2025 and a floor of $22.3 million in Q3 2021.
  • Median Current Deferred Revenue over the past 5 years was $34.4 million (2023), compared with a mean of $37.3 million.
  • Biggest five-year swings in Current Deferred Revenue: soared 184.07% in 2021 and later dropped 25.3% in 2024.
  • AdaptHealth's Current Deferred Revenue stood at $31.4 million in 2021, then grew by 0.86% to $31.6 million in 2022, then rose by 21.9% to $38.6 million in 2023, then dropped by 9.4% to $34.9 million in 2024, then surged by 71.25% to $59.8 million in 2025.
  • The last three reported values for Current Deferred Revenue were $59.8 million (Q4 2025), $59.9 million (Q3 2025), and $56.3 million (Q2 2025) per Business Quant data.